Charles D. Hyman’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $7.91M | Sell |
190,354
-9,935
| -5% | -$445K | 0.44% | 48 |
|
|
2024
Q1 | $10.9M | Sell |
200,289
-2,135
| -1% | -$109K | 0.6% | 42 |
|
|
2023
Q4 | $10.4M | Sell |
202,424
-15,245
| -7% | -$800K | 0.62% | 39 |
|
|
2023
Q3 | $12.6M | Sell |
217,669
-300
| -0.1% | -$18.4K | 0.82% | 39 |
|
|
2023
Q2 | $13.9M | Buy |
217,969
+100
| +0% | +$6.71K | 0.87% | 37 |
|
|
2023
Q1 | $15.1M | Sell |
217,869
-1,350
| -0.6% | -$95.2K | 1.01% | 33 |
|
|
2022
Q4 | $15.8M | Sell |
219,219
-753
| -0.3% | -$56.8K | 1.08% | 34 |
|
|
2022
Q3 | $15.6M | Sell |
219,972
-3,226
| -1% | -$234K | 1.2% | 26 |
|
|
2022
Q2 | $17.2M | Buy |
223,198
+850
| +0.4% | +$64.7K | 1.25% | 26 |
|
|
2022
Q1 | $16.2M | Buy |
222,348
+15,396
| +7% | +$1.03M | 1.03% | 31 |
|
|
2021
Q4 | $12.9M | Sell |
206,952
-196
| -0.1% | -$11.5K | 0.82% | 35 |
|
|
2021
Q3 | $12.3M | Sell |
207,148
-2,755
| -1% | -$181K | 0.86% | 35 |
|
|
2021
Q2 | $14M | Sell |
209,903
-3,491
| -2% | -$228K | 0.98% | 32 |
|
|
2021
Q1 | $13.5M | Hold |
213,394
| – | – | 0.99% | 34 |
|
|
2020
Q4 | $13.2M | Buy |
213,394
+859
| +0.4% | +$52.8K | 1.06% | 32 |
|
|
2020
Q3 | $12.8M | Sell |
212,535
-4,369
| -2% | -$263K | 1.13% | 29 |
|
|
2020
Q2 | $12.8M | Buy |
216,904
+28,569
| +15% | +$1.71M | 1.23% | 29 |
|
|
2020
Q1 | $10.5M | Sell |
188,335
-2,017
| -1% | -$123K | 1.32% | 28 |
|
|
2019
Q4 | $12.2M | Buy |
190,352
+907
| +0.5% | +$51.9K | 1.2% | 31 |
|
|
2019
Q3 | $9.61M | Sell |
189,445
-1,700
| -0.9% | -$79.9K | 1% | 36 |
|
|
2019
Q2 | $8.67M | Buy |
191,145
+230
| +0.1% | +$10.7K | 0.9% | 37 |
|
|
2019
Q1 | $9.11M | Buy |
190,915
+6,439
| +3% | +$321K | 0.94% | 37 |
|
|
2018
Q4 | $9.59M | Sell |
184,476
-770
| -0.4% | -$41.4K | 1.14% | 31 |
|
|
2018
Q3 | $11.5M | Sell |
185,246
-1,195
| -0.6% | -$70.9K | 1.19% | 31 |
|
|
2018
Q2 | $10.3M | Buy |
186,441
+1,545
| +0.8% | +$83.4K | 1.16% | 29 |
|
|
2018
Q1 | $11.7M | Sell |
184,896
-875
| -0.5% | -$56.3K | 1.35% | 24 |
|
|
2017
Q4 | $11.4M | Sell |
185,771
-8,556
| -4% | -$535K | 1.31% | 27 |
|
|
2017
Q3 | $12.4M | Sell |
194,327
-2,102
| -1% | -$123K | 1.54% | 24 |
|
|
2017
Q2 | $10.9M | Buy |
196,429
+1,101
| +0.6% | +$59.9K | 1.4% | 27 |
|
|
2017
Q1 | $10.6M | Sell |
195,328
-2,198
| -1% | -$121K | 1.41% | 30 |
|
|
2016
Q4 | $11.5M | Sell |
197,526
-1,300
| -0.7% | -$71.1K | 1.63% | 22 |
|
|
2016
Q3 | $10.7M | Sell |
198,826
-800
| -0.4% | -$51.4K | 1.59% | 22 |
|
|
2016
Q2 | $14.7M | Buy |
199,626
+1,075
| +0.5% | +$76K | 2.2% | 10 |
|
|
2016
Q1 | $12.7M | Sell |
198,551
-3,400
| -2% | -$214K | 2.01% | 12 |
|
|
2015
Q4 | $13.9M | Sell |
201,951
-2,175
| -1% | -$144K | 2.29% | 9 |
|
|
2015
Q3 | $12.1M | Sell |
204,126
-6,675
| -3% | -$423K | 2.12% | 11 |
|
|
2015
Q2 | $14M | Sell |
210,801
-755
| -0.4% | -$49.8K | 2.25% | 8 |
|
|
2015
Q1 | $13.6M | Sell |
211,556
-1,396
| -0.7% | -$87.4K | 2.19% | 12 |
|
|
2014
Q4 | $12.6M | Sell |
212,952
-5,740
| -3% | -$324K | 2.03% | 15 |
|
|
2014
Q3 | $11.2M | Sell |
218,692
-1,890
| -0.9% | -$94.4K | 1.87% | 16 |
|
|
2014
Q2 | $10.7M | Sell |
220,582
-1,460
| -0.7% | -$71.9K | 1.8% | 16 |
|
|
2014
Q1 | $11.5M | Sell |
222,042
-3,300
| -1% | -$176K | 2.08% | 13 |
|
|
2013
Q4 | $12M | Sell |
225,342
-3,850
| -2% | -$196K | 2.2% | 13 |
|
|
2013
Q3 | $10.6M | Sell |
229,192
-3,013
| -1% | -$132K | 2.1% | 13 |
|
|
2013
Q2 | $10.4M | Buy |
+232,205
| New | +$10.1M | 2.13% | 13 |
|
Other funds holding BMY
Charles D. Hyman's BMY Position: Q2 2024 in Review
Charles D. Hyman reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2024, selling an estimated $445K and leaving 190,354 shares worth $7.91M. The position accounts for 0.44% of the portfolio, ranked #48.
Charles D. Hyman first reported a position in BMY in Q2 2013 and has held it in 45 quarters since. The position peaked at $17.2M in Q2 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Charles D. Hyman held 190,354 shares of Bristol-Myers Squibb worth $7.91M as of Q2 2024.
- Charles D. Hyman sold 9,935 Bristol-Myers Squibb shares in Q2 2024, an estimated $445K.
- Bristol-Myers Squibb made up 0.44% of Charles D. Hyman's portfolio in Q2 2024, its #48 holding.
- Charles D. Hyman first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 45 quarters since.
- Charles D. Hyman's Bristol-Myers Squibb position peaked at $17.2M in Q2 2022.
- 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.